From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Novacyt: there was no MPOX bonanza, shares collapse as I predicted

By Tom Winnifrith | Tuesday 20 August 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


We are not allowed to call it MonkeyPox any more as the virus comes from Africa so that would be racist. I kid you not, that is why it is called MPOX and it is the latest scare story from the folks who insisted that we all lock ourselves inside for months to stop a disease where, unless you have a co-morbidity issue the survival rate was 99.99%. Anyhow unless you have lots of casual gay sex you, will as a European, probably will not catch MPOX either and if you do you are exceedingly unlikely to die.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 11:20:29